Indian Contract Manufacturing - A Hot Opportunity
Single User PDF Format: US$ 900.00
Multi-User License: US$ 1,500.00
Hard Copy: US$ 1,000.00
CD-ROM: US$ 1,000.00
The global pharmaceutical contract manufacturing industry has registered strong growth during the past few years. Amongst many other countries adopting the model, India has emerged as a market leader in pharma outsourcing. Outsourcing of drugs manufacturing provides many advantages for the pharmaceutical companies, such as enhanced production capacity, easier access to a large number of destination countries, and low scale up cost. Contract manufacturing will help the pharmaceutical companies to meet with the growing demand for new drugs and improve their core competencies.
According to our new research report “Indian Contract Manufacturing - A Hot Opportunity”, the demand for contract manufacturing services in India has been consistently rising due to the increasing cost pressure on pharmaceutical companies. The recent global economic slowdown was also a major factor for the adoption of contract manufacturing model. Leading pharma companies in the market are also looking at this model as a means to expand into the bio-similars and generics segment. With the changing economic scenario and the pressure of reducing drugs manufacturing cost, Indian contract manufacturing market is expected to grow at a CAGR of around 45.5% during 2011-2013.
We have also found that pharma manufacturing process is highly developed in some of the prominent states in the country, such as Gujarat and Maharashtra. Thus, to present a clear picture, we have incorporated the regional analysis of India along with the analysis of pharma market in the developed and emerging states. Drugs manufactured by the contract manufacturing companies in India are utilized for the local markets and exported to other major regions in the Asia-Pacific region, Middle East, and Africa.
The report provides an extensive research and prudent analysis of the Indian contract manufacturing industry. It gives an insight into the current and future market trends, and provides a brief overview of the regulatory environment in India regarding IP protection, export, and data protection. The report has also studied key contract manufacturers in the countries to help clients understand the overall market dynamics. The report will work as an investment guide for the clients looking to invest or outsource their manufacturing process in the Indian market.
Multi-User License: US$ 1,500.00
Hard Copy: US$ 1,000.00
CD-ROM: US$ 1,000.00
The global pharmaceutical contract manufacturing industry has registered strong growth during the past few years. Amongst many other countries adopting the model, India has emerged as a market leader in pharma outsourcing. Outsourcing of drugs manufacturing provides many advantages for the pharmaceutical companies, such as enhanced production capacity, easier access to a large number of destination countries, and low scale up cost. Contract manufacturing will help the pharmaceutical companies to meet with the growing demand for new drugs and improve their core competencies.
According to our new research report “Indian Contract Manufacturing - A Hot Opportunity”, the demand for contract manufacturing services in India has been consistently rising due to the increasing cost pressure on pharmaceutical companies. The recent global economic slowdown was also a major factor for the adoption of contract manufacturing model. Leading pharma companies in the market are also looking at this model as a means to expand into the bio-similars and generics segment. With the changing economic scenario and the pressure of reducing drugs manufacturing cost, Indian contract manufacturing market is expected to grow at a CAGR of around 45.5% during 2011-2013.
We have also found that pharma manufacturing process is highly developed in some of the prominent states in the country, such as Gujarat and Maharashtra. Thus, to present a clear picture, we have incorporated the regional analysis of India along with the analysis of pharma market in the developed and emerging states. Drugs manufactured by the contract manufacturing companies in India are utilized for the local markets and exported to other major regions in the Asia-Pacific region, Middle East, and Africa.
The report provides an extensive research and prudent analysis of the Indian contract manufacturing industry. It gives an insight into the current and future market trends, and provides a brief overview of the regulatory environment in India regarding IP protection, export, and data protection. The report has also studied key contract manufacturers in the countries to help clients understand the overall market dynamics. The report will work as an investment guide for the clients looking to invest or outsource their manufacturing process in the Indian market.
1. ANALYST VIEW
2. RESEARCH METHODOLOGY
3. MARKET OVERVIEW
4. REGIONAL OUTLOOK AND SCOPE
4.1 Developed Regions
4.1.1 Gujarat
4.1.2 Maharashtra
4.1.3 Andhra Pradesh
4.1.4 West Bengal
4.2 Upcoming Regions
4.2.1 Assam
4.2.2 Himachal Pradesh
4.2.3 Orissa
5. MARKET ANALYSIS
5.1 Market Trends and Drivers
5.1.1 More Focus on Quality Products and GMP Regulations
5.1.2 Supplementary Services in Pharma Outsourcing
5.1.3 Emergence of Bio Manufacturing
5.1.4 Collaboration: A Preferred Way of Market Penetration
5.2 Current Industry Issues
5.2.1 IP Issues
5.2.2 Quality Assurance Risk
5.2.3 Inefficient Project Handling and Delivery
6. REGULATORY ENVIRONMENT
7. COMPETITIVE ANALYSIS
7.1 Piramal Healthcare Limited
7.2 Dishman Pharmaceuticals and Chemicals Ltd.
7.3 Dr. Reddy’s Laboratories Ltd.
7.4 Jubilant Life Sciences
7.5 Wockhardt Ltd.
2. RESEARCH METHODOLOGY
3. MARKET OVERVIEW
4. REGIONAL OUTLOOK AND SCOPE
4.1 Developed Regions
4.1.1 Gujarat
4.1.2 Maharashtra
4.1.3 Andhra Pradesh
4.1.4 West Bengal
4.2 Upcoming Regions
4.2.1 Assam
4.2.2 Himachal Pradesh
4.2.3 Orissa
5. MARKET ANALYSIS
5.1 Market Trends and Drivers
5.1.1 More Focus on Quality Products and GMP Regulations
5.1.2 Supplementary Services in Pharma Outsourcing
5.1.3 Emergence of Bio Manufacturing
5.1.4 Collaboration: A Preferred Way of Market Penetration
5.2 Current Industry Issues
5.2.1 IP Issues
5.2.2 Quality Assurance Risk
5.2.3 Inefficient Project Handling and Delivery
6. REGULATORY ENVIRONMENT
7. COMPETITIVE ANALYSIS
7.1 Piramal Healthcare Limited
7.2 Dishman Pharmaceuticals and Chemicals Ltd.
7.3 Dr. Reddy’s Laboratories Ltd.
7.4 Jubilant Life Sciences
7.5 Wockhardt Ltd.
LIST OF FIGURES:
Figure 3-1: Pharma Outsourcing Services Market (Billion US$), 2008-2013
Figure 3-2: Pharma Contract Manufacturing Market (Million US$), 2009-2013
Figure 4-1: Regional Distribution of Pharmaceutical Manufacturing Units (%), 2010
Figure 4-2: Distribution of Pharmaceutical Clusters
Figure 4-3: Distribution of WHO GMP Certified Manufacturing Units in Gujarat (%)
Figure 4-4: Share of Gujarat in US FDA Approved Companies (2010)
Figure 4-5: Distribution of Schedule ‘M’ Compliant Pharmaceutical Manufacturing Units in Maharashtra (%), 2009
Figure 4-6: Share of Andhra Pradesh in Bulk Drugs Manufacturing
Figure 4-7: Share of Andhra Pradesh in Bulk Drugs Export
Figure 3-1: Pharma Outsourcing Services Market (Billion US$), 2008-2013
Figure 3-2: Pharma Contract Manufacturing Market (Million US$), 2009-2013
Figure 4-1: Regional Distribution of Pharmaceutical Manufacturing Units (%), 2010
Figure 4-2: Distribution of Pharmaceutical Clusters
Figure 4-3: Distribution of WHO GMP Certified Manufacturing Units in Gujarat (%)
Figure 4-4: Share of Gujarat in US FDA Approved Companies (2010)
Figure 4-5: Distribution of Schedule ‘M’ Compliant Pharmaceutical Manufacturing Units in Maharashtra (%), 2009
Figure 4-6: Share of Andhra Pradesh in Bulk Drugs Manufacturing
Figure 4-7: Share of Andhra Pradesh in Bulk Drugs Export
LIST OF TABLES:
Table 4-1: Summary of Issued and Commissioned Pharmaceutical Projects in Gujarat
Table 4-2: Potential Manpower Availability in Gujarat (2009)
Table 4-3: Potential Manpower Availability in Maharashtra
Table 4-4: Potential Manpower Availability in Andhra Pradesh (2009)
Table 4-5: Potential Manpower Availability in West Bengal (2009)
Table 7-1: Piramal Healthcare Limited - Strengths & Weaknesses
Table 7-2: Dishman Pharmaceuticals and Chemicals Ltd - Strengths & Weaknesses
Table 7-3: Dr. Reddy’s Laboratories Ltd. - Strengths & Weaknesses
Table 7-4: Jubilant Life Sciences Ltd - Strengths & Weaknesses
Table 7-5: Wockhardt - Strengths & Weaknesses
Table 4-1: Summary of Issued and Commissioned Pharmaceutical Projects in Gujarat
Table 4-2: Potential Manpower Availability in Gujarat (2009)
Table 4-3: Potential Manpower Availability in Maharashtra
Table 4-4: Potential Manpower Availability in Andhra Pradesh (2009)
Table 4-5: Potential Manpower Availability in West Bengal (2009)
Table 7-1: Piramal Healthcare Limited - Strengths & Weaknesses
Table 7-2: Dishman Pharmaceuticals and Chemicals Ltd - Strengths & Weaknesses
Table 7-3: Dr. Reddy’s Laboratories Ltd. - Strengths & Weaknesses
Table 7-4: Jubilant Life Sciences Ltd - Strengths & Weaknesses
Table 7-5: Wockhardt - Strengths & Weaknesses
